PP2A alpha [p Tyr307] Antibody (3F11) - BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-15142
Recombinant monoclonal antibody expressed in HEK293F cells
Key Product Details
Validated by
Biological Validation
Species Reactivity
Human
Applications
ELISA, Western Blot
Label
Unconjugated
Antibody Source
Recombinant Monoclonal Rabbit IgG Clone # 3F11
Format
BSA Free
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
A synthesized peptide derived from human Phospho-PP2A alpha (Y307). UniProt ID (P67775).
Clonality
Monoclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for PP2A alpha [p Tyr307] Antibody (3F11) - BSA Free
Western Blot: PP2A alpha [p Tyr307] Antibody (3F11) [NBP3-15142] - Positive WB detected in A549 whole cell lysate (treated with EGF or not). All lanes PP2A alpha antibody at 0.95ug/ml. Secondary: Goat polyclonal to rabbit IgG at 1/50000 dilution. Predicted band size: 35 KDa. Observed band size: 35 KDa.
Applications for PP2A alpha [p Tyr307] Antibody (3F11) - BSA Free
Application
Recommended Usage
Western Blot
1:500-1:5000
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, pH 7.4, 150mM NaCl, and 50% glycerol
Format
BSA Free
Preservative
0.02% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20 to -70C. Avoid freeze-thaw cycles.
Background: PP2A
Alternate Names
PP2CA, PPP2CA, RP-C
Gene Symbol
PPP2CA
Additional PP2A Products
Product Documents for PP2A alpha [p Tyr307] Antibody (3F11) - BSA Free
Product Specific Notices for PP2A alpha [p Tyr307] Antibody (3F11) - BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...